Potential Synthetic Adaptogens V: synthesis of cage monoamines by the Schwenk–Papa reaction
Laboratory analysis · 2019
- What was studied
- Preclinical research; no human efficacy established
- Main finding
- Camphor oximes yielded cage amines; norcamphor and adamantanone oximes also produced alcohol by-products. These intermediates support camphane/norcamphane replacements for adamantane scaffolds. This is synthesis research, not an efficacy trial.
Study data at a glance
- Participants or experimental model
- Preclinical research; no human efficacy established
- Reported results
- Camphor oximes yielded cage amines; norcamphor and adamantanone oximes also produced alcohol by-products. These intermediates support camphane/norcamphane replacements for adamantane scaffolds. This is synthesis research, not an efficacy trial.
Study limitations and source details
Study limitations
- Chemistry and preclinical observations do not establish human efficacy or safety.
Source details
Source identity and selected abstract or text passages checked; complete methods not appraised.
Sources checked
Citation
Author unconfirmed. Potential Synthetic Adaptogens V: synthesis of cage monoamines by the Schwenk–Papa reaction Zhurnal Organicheskoi Khimii. 55(11):1781–1788
Study source ↗ · DOI 10.1134/S051474921911017X · Bibliography entry · Link to this summary
Related compounds
Bromantane
A synthetic adamantane drug, also called Ladasten, studied in Russian fatigue and stress research.
Chlodantane
N-(adamantan-2-yl)-4-chlorobenzamide (ADK-910), an experimental small molecule with an adamantane cage joined to a chlorobenzamide. Russian studies examined temperature stress and physical workload.
Camphane chlorobenzamide
An experimental chlorobenzamide designed as a structural analogue of Chlodantane. It has a camphane cage in place of Chlodantane’s adamantane cage.